Aarey Drugs & Pharmaceuticals Ltd.

View in App
54.40 +1.15 ▲2.2%

26 April 2024, 04:02:41 PM
Volume: 122,637

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.aareydrugs.com
Market Cap 154.07 Cr.
Enterprise Value(EV) 191.45 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 1.35 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 40.77 Trailing Twelve Months Ending 2023-12
Industry PE 41.99 Trailing Twelve Months Ending 2023-12
Book Value / Share 46.67 Trailing Twelve Months Ending 2023-12
Price to Book Value 1.18 Calculated using Price: 54.92
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 2.81 Cr. 28,054,303 Shares
FaceValue 10
About Aarey Drugs & Pharmaceuticals Ltd.
Aarey Drugs & Pharmaceuticals Ltd. was established in 1990. The company is engaged in the manufacturing of drugs and intermediates such as metronidazole, metronidazole benzoate, methyl, and nitro imidazole. The company is based in Thane, India.

Aarey Drugs & Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Aarey Drugs & Pharmaceuticals Ltd. Performance

View details >>
1 Day
+2.16%
1 Week
+16.74%
1 Month
+16.36%
3 Month
+6.04%
6 Month
+29.83%
1 Year
+98.54%
2 Year
+22.94%
5 Year
10 Year

Aarey Drugs & Pharmaceuticals Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 3.12 3.58 12.9 9.8 8.07 6.65 6.98 6.31 3.33
Return on Capital Employed (%) 6.69 7.23 22.21 14.14 12.05 8.48 9.46 9.87 6.27
Return on Assets (%) 0.98 1.07 4.09 3.96 4.15 3.41 3.05 2.74 1.41

Aarey Drugs & Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 35 37 49 80 87 92 99 114 117 119
Non Curr. Liab. 0 2 1 2 1 3 5 6 5
Curr. Liab. 80 88 92 88 58 100 131 127 168 110
Minority Int.
Equity & Liab. 115 125 143 170 146 194 233 245 291 234
Non Curr. Assets 6 8 13 13 13 13 15 26 21 16
Curr. Assets 109 117 130 157 133 181 218 219 271 218
Misc. Exp. not W/O 0
Total Assets 115 125 143 170 146 194 233 245 291 234

Aarey Drugs & Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 213 246 396 349 355 300 348 493 419 343
Other Income 3 3 3 3 4 7 7 3 3 7
Total Income 216 249 399 352 359 307 355 495 422 351
Total Expenditure -212 -245 -386 -341 -347 -297 -344 -481 -411 -340
PBIDT 4 4 13 11 12 10 12 14 10 11
Interest -1 -2 -4 -2 -2 -2 -2 -2 -3 -4
Depreciation -1 -1 -1 -1 -1 -1 -1 -2 -2 -2
Taxation 0 -1 -3 -2 -2 -1 -2 -3 -2 -2
Exceptional Items
PAT 1 1 5 6 7 6 7 7 4 4
Adjusted EPS 1 1 3 3 3 2 3 3 1 1

Aarey Drugs & Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 3 6 1 -20 1 3 5 1 -1
Cash Fr. Inv. 2 -2 -3 -5 -1 -1 -1 -3 -3 0
Cash Fr. Finan. -1 -2 -2 4 23 -2 -2 -2 2 1
Net Change 0 -1 1 -1 2 -3 0 0 0 1
Cash & Cash Eqvt 1 0 2 1 3 0 1 1 0 1

Aarey Drugs & Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 48.06 50.03 50.03 50.03 50.04 50.04 50.04 50.04 45.28
Public 51.94 49.97 49.97 49.97 49.96 49.96 49.96 49.96 54.72
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Aarey Drugs & Pharmaceuticals Ltd. Announcements

View details >>
Mon, 22 Apr 2024
Disclosure under SEBI Takeover Regulations
Aarey Drugs & Pharmaceuticals Limitedￂﾠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaￂﾠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011.ￂﾠ
Fri, 12 Apr 2024
Statement of deviation(s) or variation(s) under Reg. 32
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
Wed, 10 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Aarey Drugs & Pharmaceuticals Ltd. Technical Scans

View details >>
Fri, 26 Apr 2024
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Closing Above Previous High Closing Above Previous High
Closing Above Previous High For 3 Days Closing Above Previous High For 3 Days

Aarey Drugs & Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 360,919.96 1,506.55 -0.9%
Cipla Ltd. 113,794.25 1,409.15 +0.2%
Divi's Laboratories Ltd. 106,860.39 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. 104,315.63 6,252.10 +0.5%
Zydus Lifesciences Ltd. 95,380.92 947.40 -0.4%
Mankind Pharma Ltd. 94,869.36 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. 91,057.05 2,691.00 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.52 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-12 30.69 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-12 77.27 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.95 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.07 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-12 54.93 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.95 2,691.00 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.78 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-12 4.39 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-12 8.20 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.88 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.06 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-12 10.68 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.73 2,691.00 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,691.00 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,691.00 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,691.00 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,691.00 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,691.00 -0.1%

Aarey Drugs & Pharmaceuticals Ltd. FAQ's

What is Aarey Drugs & Pharma share price?
Can I buy Aarey Drugs & Pharma shares now?
What is the Market Cap of Aarey Drugs & Pharma?
What are the key metrics to analyse Aarey Drugs & Pharma?
What is the 52 Week High and Low of Aarey Drugs & Pharma?
What is the trend of Aarey Drugs & Pharma share price?